Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

385 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characterization of Aldosterone-producing Cell Cluster (APCC) at Single-cell Resolution.
Iwahashi N, Umakoshi H, Seki T, Gomez-Sanchez CE, Mukai K, Suematsu M, Umezawa Y, Oya M, Kosaka T, Seki M, Suzuki Y, Horiuchi Y, Ogawa Y, Nishimoto K. Iwahashi N, et al. Among authors: umezawa y. J Clin Endocrinol Metab. 2022 Aug 18;107(9):2439-2448. doi: 10.1210/clinem/dgac394. J Clin Endocrinol Metab. 2022. PMID: 35796577 Free PMC article.
Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma.
Murakami T, Kikuchi E, Ide H, Umezawa Y, Takahashi T, Izawa M, Hakozaki K, Shigeta K, Ogihara K, Kobayashi H, Kanai K, Maeda T, Yoshimine S, Mizuno R, Nishimoto K, Oya M. Murakami T, et al. Among authors: umezawa y. BJUI Compass. 2021 Mar 9;2(5):322-330. doi: 10.1002/bco2.81. eCollection 2021 Sep. BJUI Compass. 2021. PMID: 35474877 Free PMC article.
Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long-term treatment-free survival with pembrolizumab and axitinib in the KEYNOTE-426 phase III trial of pembrolizumab and axitinib versus sunitinib.
Nishimoto K, Shirotake S, Miyama Y, Kaneko G, Kanao K, Igarashi D, Takahashi T, Umezawa Y, Yasuda M, Oyama M. Nishimoto K, et al. Among authors: umezawa y. IJU Case Rep. 2022 Feb 18;5(3):149-152. doi: 10.1002/iju5.12422. eCollection 2022 May. IJU Case Rep. 2022. PMID: 35509782 Free PMC article.
Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivation therapy alone.
Kanao K, Takahashi T, Umezawa Y, Okabe T, Kaneko G, Shirotake S, Nishimoto K, Oyama M. Kanao K, et al. Among authors: umezawa y. PLoS One. 2022 Oct 20;17(10):e0276081. doi: 10.1371/journal.pone.0276081. eCollection 2022. PLoS One. 2022. PMID: 36264927 Free PMC article.
A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis-assisted transurethral resection involving orally administered 5-aminolevulinic acid.
Watanabe K, Shirotake S, Umezawa Y, Takahashi T, Yamanaka T, L Santo N, Okabe T, Kaneko G, Sano K, Yasuda M, Kanao K, Oyama M, Nishimoto K. Watanabe K, et al. Among authors: umezawa y. IJU Case Rep. 2019 Sep 13;2(6):313-316. doi: 10.1002/iju5.12109. eCollection 2019 Nov. IJU Case Rep. 2019. PMID: 32743447 Free PMC article.
385 results